Abstract:Stromal cells are physiologically essential components of the tumor microenvironment (TME) that mediates tumor development and therapeutic resistance. Development of a logical and unified system for stromal cell type identification and characterization of corresponding functional properties could help design antitumor strategies that target stromal cells. Here, we performed a pan-cancer analysis of 214,972 nonimmune stromal cells using single-cell RNA sequencing from 258 patients across 16 cancer types and analyzed spatial transcriptomics from 16 patients across seven cancer types, including six patients receiving anti–PD-1 treatment. This analysis uncovered distinct features of 39 stromal subsets across cancer types, including various functional modules, spatial locations, and clinical and therapeutic relevance. Tumor-associated PGF+ endothelial tip cells with elevated epithelial–mesenchymal transition features were enriched in immune-depleted TME and associated with poor prognosis. Fibrogenic and vascular pericytes (PC) derived from FABP4+ progenitors were two distinct tumor-associated PC subpopulations that strongly interacted with PGF+ tips, resulting in excess extracellular matrix (ECM) abundance and dysfunctional vasculature. Importantly, ECM-related cancer-associated fibroblasts enriched at the tumor boundary acted as a barrier to exclude immune cells, interacted with malignant cells to promote tumor progression, and regulated exhausted CD8+ T cells via immune checkpoint ligand–receptors (e.g., LGALS9/TIM-3) to promote immune escape. In addition, an interactive web-based tool (http://www.scpanstroma.yelab.site/) was developed for accessing, visualizing, and analyzing stromal data. Taken together, this study provides a systematic view of the highly heterogeneous stromal populations across cancer types and suggests future avenues for designing therapies to overcome the tumor-promoting functions of stromal cells. Significance: Comprehensive characterization of tumor-associated nonimmune stromal cells provides a robust resource for dissecting tumor microenvironment complexity and guiding stroma-targeted therapy development across multiple human cancer types.

Engineering stromal heterogeneity in cancer

Simulating the Dynamic Intra-Tumor Heterogeneity and Therapeutic Responses

Heterogeneity in Primary Tumors and Corresponding Metastases: Could It Provide Us with Any Hints to Personalize Cancer Therapy?

A physical mechanism of heterogeneity in stem cell, cancer and cancer stem cell

Stochastic population dynamics of cancer stemness and adaptive response to therapies

Cancer stem cells and the tumor microenvironment: interplay in tumor heterogeneity

Heterogeneity in Circulating Tumor Cells: The Relevance of the Stem-Cell Subset

Heterogeneity in cancer stem cells.

Examining Heterogeneity of Stromal Cells in Tumor Microenvironment Based on Pan-Cancer Single-Cell RNA Sequencing Data

Tumour Heterogeneity: The Key Advantages of Single-Cell Analysis

A narrative review of tumor heterogeneity and challenges to tumor drug therapy

Impact of the Tumor Microenvironment on Tumor Heterogeneity and Consequences for Cancer Cell Plasticity and Stemness

Tumor organoids: applications in cancer modeling and potentials in precision medicine

Dynamics Between Cancer Cell Subpopulations Reveals A Model Coordinating With Both Hierarchical And Stochastic Concepts

3D cell culture systems modeling tumor growth determinants in cancer target discovery

Metabolic Heterogeneity in Cancer: an Overview and Therapeutic Implications

Remodeling of Stromal Cells and Immune Landscape in Microenvironment During Tumor Progression

Rebuilding the microenvironment of primary tumors in humans: a focus on stroma

From complexity to clarity: unravelling tumor heterogeneity through the lens of tumor microenvironment for innovative cancer therapy

Integration of Pan-Cancer Single-Cell and Spatial Transcriptomics Reveals Stromal Cell Features and Therapeutic Targets in Tumor Microenvironment

Breast cancer heterogeneity through the lens of single-cell analysis and spatial pathologies